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Abstract
The intracellular transducing device consists of complex networks of enzymatic reactions. Unfortunately, the mathematical
models commonly used to describe them are still unsatisfactory and unreliable, even at the level of reproducing simple reaction
schemes. The improvement of mathematical models is necessary and can follow different approaches still poorly employed, such
as the modeling of spatial structures and phenomena, time delays, stochastic perturbations, only to cite the most relevant ones. In
this paper we show some recent results related to the total quasi-steady-state approximation (tQSSA), in a deterministic scenario.
Moreover, we show some possible applications of the tQSSA in a stochastic scheme.
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1. Introduction
Every year, pharma companies invest billions of dollars on lead compound research, with the aim of drug discovery
and commercialization. Most of these costs concern laboratory experiments (in vitro and in vivo) and clinical tests.
One of the main goals of the so-called ‘Systems Biology’ is to help the pharmaceutical research in dramatically
reducing the costs of the research phases (mostly preclinical ones) preceding drug commercialization and the time
needed to complete all these phases.
The completion (in some sense) of the Human Genome Project, aimed at sequencing the complete human genome,
raised great excitation in the genetics community, because this “primary” (genomic) information was believed to
be the first step towards the unification between proteomic and genomic data and its use in medical, clinical and
pharmaceutical fields. This effort would have brought complete information not only to basic research but also to
medical applications to find the best treatment for human disease.
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The expected results, human gene mapping and specific drug design to modulate gene expression and protein
targets, targeted gene engineering and so on, have been disappointing. As can been seen in [1] (see Fig. 1 of that
paper), a constant decline in pharmaceutical production began at the middle of the seventies and persisted throughout
the “genomic era”. The goal of having a complete list of human genes and, consequently, of the complete list of
potential gene and protein targets has not been reached, because of the relatively low number of human genes (more
or less one-fourth of the expected number) and of the high complexity of gene regulation and protein domain folding.
The proteomic level is, in fact, more complex than expected and many “emergent” properties of protein interactome
cannot be inferred from the knowledge of the primary structure of a genome. Another level of complexity is the gene
transcription, whose general rules escape our efforts in the study of regulation regions surrounding the genes. The
potential targets of drugs have exponentially grown in number, and the genomic information is largely insufficient to
lead to drug discovery and therapy design.
Succinctly put, the genomic approach alone is not a successful way to deal with the drug design task. At least,
we can say that no beneficial boost has been experienced by drug research during the period (1985–2005) of human
genome sequencing. The expected result was the dramatic reduction of the time and cost of the so-called preclinical
phase of drug production, the one in which bioinformatic, computational and theoretical methods would have helped
to select the promising gene and protein targets.
The recent estimate of the costs for new drug development (see [2], Fig. 2), based on data of the eighties, for the
preclinical and clinical studies and trials, is of more than 800M US $ for the total course of drug commercialization (a
period of about ten years). But a more recent estimate raises these costs to more than 1000M US $ for each successful
drug.
Finally, the success rate of the trials is, in the best actual cases, no more than 30% (see [2], Table 1). It can be
estimated that a mean of only 10% of the tested new compounds will be commercialized (with a good profit for the
pharmas and a beneficial effect on public healthy), and the amount of nonsuccessful research is easily evaluated.
These data highlight the need for new conceptual tools for effective drug discovery. In other words, it is not the
large-scale extension of (otherwise) successful experimental and computational tools to improve the pharmaceutical
research. A conclusion can be drawn from these data: since the research on new drugs is guided by empirical and
trial methods, it would be more efficient to develop new tools for the preclinical phase of the research, i.e. the
introduction of new powerful theoretical schemes, based on the huge quantity of experimental data on cell biology and
biochemistry. These new tools, which are of most interest in the field of Systems Biology, are mathematical models
and computer software to accurately reproduce the intracellular and intercellular phenomena in a quantitative way. A
robust predictive mathematical model must be used to address the experimental activity following initial research
stages. In other words, the experimental activity must be targeted on a more massive production of quantitative
data (kinetic constants, molecular concentrations, geometrical data on the cell structure, etc.) which will be used
for the mathematical model construction. The accuracy of these data, together with reliable proteomic data (for
example, protein interaction map data) will allow the formulation of mathematical models of increasing complexity
and large-scale on the various aspects of the intra and intercellular phenomena. This “virtual cell” project, which has
been successfully begun at the end of nineties [3,4] on some selected well-known intracellular signal transduction
pathways (MAP kinase cascade, NFkB pathway and others), needs an extension of the present understanding of
protein interaction events, for example a reconsideration of the well-known Michaelis–Menten reaction scheme is
needed to be reconciled with the highly connected structure of intracellular signal transduction pathways.
2. The systems biology approach
In the last decade, many mathematical models have been formulated to investigate the behavior of complex
intracellular biochemical networks. The aim of such modeling (which is an integral part of the ‘Systems Biology’
large-scale project) is roughly twofold: to reproduce and study some particular phenomena observed experimentally
(like bistability, oscillations, ultrasensitivity, hysteresis etc.) and to investigate the properties of these networks
as information processing and transducing devices. As a hope for the future, this modeling could be used for
pharmaceutical scopes (first of all drug discovery) as a reliable tool to make predictions about the effects of drugs
on the biochemical networks, thus shortening the preclinical phase.
A.M. Bersani et al. / Computers and Mathematics with Applications 55 (2008) 879–888 881
Surprisingly, the mathematical formulation of these highly interconnected enzyme reactions is usually based on
in vitro studies of isolated reactions, without serious criticism of the delicate passage from the kinetics of simple
reactions to the kinetics of a network of reactions shared by several cascades in a crowded molecular environment [5].
This fact can be justified when analyzing underlying mechanisms (e.g., the importance of feedback or the creation
of oscillations), where the exact kinetic expressions and parameters are less important since one is usually only
interested in the qualitative behavior that the system can perform. However, in the light of the several “virtual cell”
projects, which aim at being both a qualitative and a quantitative precise representation of the living cell, the use
of correct parameters, kinetic schemes and initial conditions i.e., steady-state concentrations of molecular species
become crucial. The mathematical efforts in this direction are still largely unsatisfactory, due to the complexity and
variety of the involved phenomena. Most of the mathematical models reproducing the signal transduction pathways
neglect the spatial and stochastic features of the cell, which is seen as a homogeneous medium in which a lot of
randomly interacting molecules are present.
In many cases, the spatial distribution of molecules is important (for example, some proteins can be activated and
interact only on the plasma membrane), while some phenomena (like the gene expression and protein production) are
intrinsically stochastic events, in which few molecules are engaged at a time. After the successes obtained by means of
the mathematical models formulated in terms of ordinary differential equations (ODEs), there is the need of extending
these models to the use of partial differential equations (PDEs, in which the nonhomogeneous spatial structure of
the cell is explicitly introduced and the subcellular compartments are treated as quantitatively different subcellular
regions) and stochastic differential equations (SDEs) to have a more complete theoretical framework and reliable
predictions. In this way, the pharmaceutical and basic research would improve the lead compound discovery and speed
up the preclinical phase of drug development, dramatically reducing the costs and accelerating the commercialization
of drugs, with enormous benefits for public health and the health national programs.
3. The deterministic approach—theoretical background
One of the principal components of the mathematical approach to Systems Biology is the model of biochemical
reactions set forth by Henri in 1901 [6–8] and Michaelis and Menten in 1913 [9], and further developed by Briggs
and Haldane in 1925 [10]. This formulation considers a reaction where a substrate S binds an enzyme E reversibly
to form a complex C . The complex can then decay irreversibly to a product P and the enzyme, which is then free to
bind another molecule of the substrate.
This process is summarized in the scheme
E + S d←− a−→ C k−→ E + P, (1)
where a, d and k are kinetic parameters (supposed constant) associated with the reaction rates.
The fundamental step is modeling all of the intermediate reactions, including binding, dissociation and release of
the product using mass action and conservation laws. This leads to an ODE for each involved complex and substrate.
We refer to this as the full system. For (1) the equations are
dS
dt
= −a(ET − C)S + dC, (2)
dC
dt
= a(ET − C)S − (d + k)C (3)
with the initial conditions
S(0) = ST , C(0) = 0, (4)
and the conservation laws
E + C = ET , S + C + P = ST . (5)
The initial conditions give the concentrations of S and C at the beginning of the reaction, and their time
development is described by the ODEs, while E and P are linked to S and C through the conservation laws. Here ET
is the total enzyme concentration assumed to be free at time t = 0. Also the total substrate concentration, ST , is free
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at t = 0. This is the so-called Michaelis–Menten (MM) kinetics [9,11,12]. Let us observe that the system (2) and (3)
admits an asymptotic solution for t →∞, obtained by setting the derivatives equal to zero. This solution is given by
C = S = 0, so that from the conservation laws P = ST and E = ET . This means that all the substrate eventually
becomes product due to the irreversibility, while the enzyme eventually is free and the complex concentration tends
to zero.
Assuming that the complex concentration is approximately constant after a short transient phase leads to the usual
Michaelis–Menten (MM) approximation, or standard quasi-steady-state approximation (standard QSSA, sQSSA). It
leads to an ODE for each substrate while the complexes are assumed to be in a quasi-steady-state (i.e., dCdt ≈ 0):
dS
dt
≈ −kC ≈ − VmaxS
KM + S , S(0) = ST , (6)
Vmax = kET , KM = d + ka . (7)
The advantage of a quasi-steady-state approximation is that it reduces the dimensionality of the system, passing
from two equations (full system) to one (MM approximation or sQSSA) and thus speeds up numerical simulations
greatly, especially for large networks as found in vivo. Moreover, the kinetic constants in (1) are usually not known,
whereas finding the kinetic parameters for the MM approximation is a standard in vitro procedure in biochemistry.
See e.g. [12] for a general introduction to this approach. We stress here that this is an approximation to the full system,
and that it is only valid when the enzyme concentration is much lower than either the substrate concentration or the
Michaelis constant KM , i.e., ET  ST + KM [11,13]. This condition is usually fulfilled for in vitro experiments, but
often breaks down in vivo [14,15]. We refer to [16] for a nice, general review of the kinetics and approximations of
(1).
However, as mentioned above, to simulate physiologically realistic in vivo scenarios, one faces the problem that
the MM approximation is no longer valid. Hence, even though the kinetic constants such as KM are identical in vivo
and in vitro, they need to be implemented in an approximation which is valid for the system under investigation.
4. The total quasi-steady-state approximation
As mentioned in the previous section, in vivo we cannot in general assume a low enzyme concentration, and hence
the MM approximation cannot be expected to hold. A recent approach to resolve this problem is that of the total
quasi-steady-state assumption (tQSSA).
It was introduced by Borghans et al. [17] and refined by Tzafriri [18] for isolated reactions. It arises by introducing
the total substrate
S = S + C, (8)
and assuming that the complex is in a quasi-steady-state as for the sQSSA. For (1) it gives [18]
dS
dt
≈ −kC−(S), S(0) = ST , (9)
where
C−(S) = (ET + KM + S)−
√
(ET + KM + S)2 − 4ET S
2
. (10)
Numerical integration of (9) easily gives the time behavior of S,C (by (10)) and S (by the relation S = S − C).
Tzafriri [18] showed that the tQSSA (9) is valid whenever
T z := K2ST
(
ET + KM + ST√
(ET + KM + ST )2 − 4ET ST
− 1
)
 1, where K = k
a
, (11)
and that this is at least roughly valid for any set of parameters, in the sense that
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This means that, for any combination of parameters and initial conditions, (9) is a decent approximation to the full
system (2) and (3). The parameter K is known as the Van Slyke–Cullen constant.
Importantly, the tQSSA uses the same parameters (Vmax, KM ) as the sQSSA. Hence, the parameters found in vitro
from the MM approach can be used by the tQSSA for modeling in vivo scenarios.
The roles of Vmax, the maximal reaction velocity, and KM , the Michaelis constant describing the concentration of
the substrate at which the reaction rate is half maximal, become essential when characterizing biochemical reactions
in vitro as well as in vivo. Moreover, the description of cooperative reactions, inhibition and many other biochemical
processes have up to now exploited the fundamental ideas of the MM scheme, i.e., the sQSSA and the parameters
Vmax and KM (see, e.g., [12]). However, since these approximations cannot be expected to be valid in vivo, employing
the tQSSA to these more complex situations would be preferable. Tzafriri and Edelman [19] studied the completely
reversible enzyme reaction in terms of the tQSSA. In [20] the tQSSA was derived for fully competitive reactions.





KM + ET + S
, S(0) = ST . (13)
This approximation is valid at low enzyme concentrations ET  ST +KM , where it reduces to the MM expression
(6), but holds moreover at low substrate concentrations ST  ET +KM [18]. Thus, with minimal effort in performing
the substitutions of S by S and of KM by KM + ET one obtains a significantly improved MM-like approximation,
without any need for more advanced mathematics.
5. The total quasi-steady-state approximation for complex reactions
The paper [20] investigated the system
S1 + E d1←− a1−→ C1 k1−→ E + P1,
S2 + E d2←− a2−→ C2 k2−→ E + P2,
(14)
which consists of two reactions catalyzed by the same enzyme, i.e., a system with competing substrates, which is
governed by the coupled ODEs [11,21,22], i = 1, 2,
dSi
dt
= −ai E · Si + diCi , Si (0) = Si,T , (15)
dCi
dt
= ai (E · Si − KiCi ), Ci (0) = 0, Ki = di + kiai (16)
and the conservation laws
Si,T = Si + Ci + Pi , i = 1, 2, ET = E + C1 + C2. (17)
The sQSSA of this system is [11,21]
dSi
dt
≈ − ki ET Si
Ki (1+ S j/K j )+ Si , Si (0) = Si,T , i = 1, 2, j 6= i, (18)
which is valid when [22]
ET
Ki (1+ S j,T /K j )+ Si,T  1, i = 1, 2, j 6= i. (19)
As in the noncompetitive case, it says that the sQSSA holds at low enzyme concentrations.
These results were improved in [20], applying the tQSSA to both reactions and showing that the tQSSA is given
by finding C1 as the unique biologically acceptable root (0 < C1 < min{ET , S1}) of the third degree polynomial
ψ1(C1) = −(K1 − K2)C31 + [(ET + K1 + S1)(K1 − K2)− (S1K2 + S2K1)]C21 + [−ET (K1 − K2)
+ (S1K2 + S2K1)+ K2(ET + K1)]S1C1 − ET K2(S1)2 (20)
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and similarly finding C2 as the root in the polynomial ψ2 obtained by interchanging the indices 1 and 2 in (20).
After a short transient phase the complex concentrations are assumed to equal the quasi-steady-state concentrations,
Ci = Ci (S1, S2), given by the roots in the respective polynomials as discussed above. Then the evolution of the
system can be studied by means of the tQSSA
dSi
dt
≈ −kiCi (S1, S2), Si (0) = Si,T . (21)
This approach extends both the sQSSA for competitive reactions (18) as well as the tQSSA for isolated reactions
(9), as shown in [20].
Let us remark that in the classical literature every single reaction of a network is often treated by an MM
approximation for an isolated reaction of the form (1), not only without any a priori examination of its applicability,
but also neglecting the complexes and the other terms involved in double reactions or in competitions. This means
that even when the sQSSA holds for every noncompetitive reaction in (14), the neglect of the complexes and of the
competition leads to wrong estimations of the behavior.
To show this fact, let us consider two important reactions: the Goldbeter–Koshland switch and the double
phosphorylation mechanism.
In [23] the tQSSA was applied to the so-called Goldbeter–Koshland switch [24]
S + E1 d1←− a1−→ C1 k1−→ E1 + P1,
P + E2 d2←− a2−→ C2 k2−→ E2 + S,
(22)
which describes, for example, the cycle of phosphorylation and dephosphorylation of a substrate, by means of a
kinase E1 and a phosphatase E2. This reaction is very important in every intracellular pathway, because the process of
phosphorylation and dephosphorylation is one of the most important process in activating and inactivating enzymes.
The reaction is governed by the coupled ODEs
dS
dt
= −a1E1 · S + d1C1 + k2C2, S(0) = ST ,
dC1
dt
= a1E1 · S − (d1 + k1)C1,
dC2
dt
= a2E2 · P − (d2 + k2)C2, Ci (0) = 0
(23)
and the conservation laws
ST = S + C1 + C2 + P, Ei,T = Ei + Ci , i = 1, 2. (24)
Introducing the total substrates S = S + C1, P = P + C2, we rewrite the Eq. (23) in the following way:
dS
dt
= k2C2 − k1C1 = −dPdt , S(0) = ST
dC1
dt
= a1(E1,T − C1) · (S − C1)− (d1 + k1)C1,
dC2
dt
= a2(ST − S − C2) · (E2,T − C2)− (d2 + k2)C2, Ci (0) = 0. (25)




≈ k2C−2 − k1C−1 , S(0) = ST (26)
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Fig. 1. The tQSSA estimates well the development of the product P of the Goldbeter–Koshland switch (scheme (22) [23]). Legends are: Full
system (circles), sQSSA (dashed line) and tQSSA (full curve), where we show PtQSSA := P − C−2 for a correct comparison between sQSSA and
tQSSA. The parameters are ST = 100, E1,T = 500, E2,T = 10, a1 = a2 = 4, d1 = d2 = 5, k1 = k2 = 1, all in arbitrary units.
where
C−1 =
(S + E1,T + K1)−
√




(ST − S + E2,T + K2)−
√
(ST − S + E2,T + K2)2 − 4(ST − S)E2,T
2
(28)
and Ki = di+kiai .
Formulas (27) and (28) show that, differently from the case of a single phosphorylation reaction, in this situation
the quasi-steady-state does not imply that the complexes tend to be negligible. In Fig. 1 [23] the simulations of the
full system and of its QSSAs are compared.
The double phosphorylation as well as double dephosphorylation was recently modeled in the context of the so-
called mitogen-activated protein kinase cascade (MAPK cascade) (see, for example, [25–29]).
As far as we know, differently from the previous examples, there is no explicit formula for the tQSSA of the double
phosphorylation mechanism
S + E d1←− a1−→ C1 k1−→ E + Sp,
Sp + E d2←− a2−→ C2 k2−→ E + Spp,
(29)
where the activating enzyme E is a kinase, which phosphorylates the substrate S. The phosphorylated molecule Sp
can bind the same enzymes, producing the double phosphorylated form Spp. The reaction scheme can be seen as a
special case of (14) with S1 = S, P1 = S2 and P2 = Spp, because S and Sp compete for the same enzyme, E , but
differently from the fully competitive reaction, it is usually assumed that at the beginning only S is present.
Consequently in [20] the tQSSA for competitive reactions was applied to this case, too, though it should be
remarked that the theoretical investigation of the validity of the tQSSA does not work in the case of successive
reactions. The problem is that there is no S2 at time t = 0, and hence the time scales cannot be found following [11]
because the definition of the transient phase no longer holds.
Nevertheless, it seems that the conclusions concerning the validity of the tQSSA from [20] carry over to this
scenario (see the three panels of Fig. 2).
As remarked above, the double phosphorylation–dephosphorylation mechanism is central in many reaction
networks and, in particular, in the MAPK cascade. This is a ubiquitous cascade, present in many cells and in many
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Fig. 2. A simulation of two successive reactions catalyzed by the same enzyme (scheme (29) [20]). In the three cases under investigation the
full system (circles) is estimated very well by the competitive tQSSA (full curve), even when its first-order approximation (dash–dot curve), the
competitive sQSSA (dotted curve) as well as the noncompetitive tQSSA (dashed curve) do not fit (panel C). Parameters are a1 = a2 = 0.2; d1 =
d2 = 1; k1 = 0.6; k2 = 0.5 (K1 = 8; K2 = 7.5; K = 3). Sp(0) = Spp(0) = 0. In A: S(0) = ST = 20. In B: S(0) = ST = 0.5. In C:
S(0) = ST = 30. All units are arbitrary.
transduction pathways, and is one of the most important and most studied subnetworks, not only by a biochemical
point of view, but also by means of mathematical models (see, for example, [30–33]).
In [34] a comparison between the application of the sQSSA and of the tQSSA to the MAPK cascade computational
model has been performed. Also in this case the double phosphorylation–dephosphorylation loops were approximated
by the tQSSA for fully competitive reactions. The tQSSA was shown to be much more effective, though better
approximations are needed for similar pathways, characterized by high complexity.
6. Numerical results
In the previous section we have shown that the use of the sQSSA can lead to gross quantitatively as well as
qualitatively wrong conclusions even in the case of simple networks. Simulations show that the tQSSA can estimate
the behavior of the systems under investigation significantly better, and therefore we propose to use this approximation
when modeling intracellular signalling networks.
Fig. 1 (see [23]) and Fig. 2 (see [34]) show various approximation schemes of the time concentration development
of the chemical species involved respectively in the Goldbeter–Koshland switch and in the double phosphorylation.
This was done by numerically solving the systems of ordinary differential equations (ODEs) derived from the reaction
schemes (22) and (29), using the methods and approximations within the various approaches.
As shown in Fig. 1, neglecting the complexes in the sQSSA brings about not only qualitatively, but also
quantitatively bad approximations of the temporal behavior of the concentrations. On the other hand, the tQSSA
fits in a very satisfactory way the solution of the full system.
Fig. 2 shows that, though without any theoretical investigation of its validity for the scheme (29), applying the
tQSSA for fully competitive reactions to this scheme brings in much better approximations than the sQSSA.
7. The stochastic approach—problems and perspectives
The small dimensions of cells and proteins imply the fact that enzymes inside the cell are subject to random
fluctuations due to Brownian motion. The randomness of enzyme displacements affects their interaction rates, mainly
when the number of proteins is very low and any description of the reactions in terms of continuous fluxes of matter
is expected not to hold anymore.
In this case the deterministic differential equations must be substituted by discrete, stochastic equations.
Starting from the pioneering works by Delbru¨ck [35] and Kramers [36] for general chemical reactions and
Bartholomay [37–39] for the Michaelis–Menten kinetics, much literature has been produced on this topic. Let us,
for instance, mention the paper [40] by Qian and Elson, where a single molecule kinetics is studied in a stochastic
framework.
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Let us consider n ≥ 1 different molecules S1, S2, . . . , Sn , interacting through m ≥ 1 reactions R1, R2, . . . , Rm
and introduce the vector X(t), describing the dynamical state of the system, whose components X i (t) represent the
number of Si molecules in the system at time t .
We can consider the probability a j (x)dt given X(t) = x, that one R j reaction will occur in the next infinitesimal
time interval [t, t + dt) and the state-change vector νj, whose i th component ν j i is defined by the change in number
of Si molecules produced by one R j reaction.
The time evolution for the probability P(x, t |x0, t0) that, for t ≥ t0, X(t) will equal x given that X(t0) = x0 is
described by the so-called chemical master equation (CME) [41]:
∂
∂t
P(x, t | x0, t0) =
m∑
j=1
[a j (x− νj)P(x− νj, t | x0, t0)− a j (x)P(x, t |x0, t0)]. (30)
The functions a j are known as propensity functions.
When we deal with enzyme kinetics and consider the probability P := P(E, S,C, P, t) that there will be present,
at time t , E molecules of the activating enzyme, S molecules of the substrate, P molecules of the product and C
molecules of the complex, the CME assumes the following form
∂P
∂t
= a(S + 1)(E + 1)P(S + 1, E + 1,C − 1, P, t)+ d(C + 1)P(S − 1, E − 1,C + 1, P, t)
+ k(C + 1)P(S, E − 1,C + 1, P − 1, t)− [aS · E + kC + dC]P(S, E,C, P, t), (31)
where the constant rates a, d, k of the reaction play the role of propensity functions.
Since in general it is not possible to analytically or numerically solve the CME, stochastic simulation algorithms
(SSAs) [42] were formulated and further improved and/or adapted to different scenarios (see [43,44] for clear and
complete reviews).
Many of these algorithms use the sQSSA, which has been shown to be inadequate in the deterministic approach
even in the simplest of reactions. It seems much more appropriate to apply the tQSSA to any SSA. This is one of the
main goals of our future research.
The stochastic nature of the enzymatic reactions leads to many other, interesting challenges for the future
researches.
As remarked above, the subnetworks we are studying, like the MAP kinase cascade, can be characterized,
in particular, by multistability, hysteresis, zero–one responses etc. The crucial role of multistationarity and
ultrasensitivity has been remarked upon by many authors (see, for example, [30–32,45,33]).
The introduction of even small stochastic fluctuations could bring about dramatic changes, like the passage of the
system from one steady-state to another one. Considering, for instance, the localization property of many reactions in
a network, we could interpret the concentration fluctuations as the changes caused by the random movements of the
enzymes, which enter in and exit from the cell compartment where the reaction is localized, changing the probabilities
of interactions.
On the other hand, since the constant rates are never really constant in time, depending on many factors, like, for
example, the molecular crowding (see, for example, [46,47,5,48,49]), we want in the future to study the effects of even
small fluctuations of the constant rates on the enzyme concentrations. In general, we may expect that, in the presence
of multistable systems, small stochastic perturbations can even bring about drastic changes in the cell behavior.
Finally, some particular subnetworks, like the above quoted double phosphorylation–dephosphorylation loop or
some more complex feedback loops, like in the MAPK cascade, can show the presence of oscillations of some
enzyme concentrations. Under suitable conditions, which must still be investigated, we could expect some extremal
phenomena, like the so-called stochastic resonance (see [50] for a complete review), where optimal small stochastic
perturbations can bring about a dramatic enhancement of the oscillation amplitude.
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